Middle East Pharmaceutical Industries Company (TADAWUL:4016)
Saudi Arabia flag Saudi Arabia · Delayed Price · Currency is SAR
137.20
+2.00 (1.48%)
Oct 30, 2025, 3:18 PM AST

TADAWUL:4016 Ratios and Metrics

Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
2,7442,436----
Enterprise Value
2,7812,496----
Last Close Price
137.20119.61----
PE Ratio
29.5430.51----
Forward PE
25.5524.86----
PS Ratio
6.356.18----
PB Ratio
7.126.62----
P/TBV Ratio
8.287.67----
P/FCF Ratio
96.09100.97----
P/OCF Ratio
58.9869.02----
EV/Sales Ratio
6.446.33----
EV/EBITDA Ratio
24.9025.19----
EV/EBIT Ratio
27.0327.95----
EV/FCF Ratio
97.37103.45----
Debt / Equity Ratio
0.160.180.200.300.330.25
Debt / EBITDA Ratio
0.540.660.731.111.050.72
Debt / FCF Ratio
2.132.710.861.443.445.49
Asset Turnover
0.840.800.760.700.73-
Inventory Turnover
1.661.681.441.371.45-
Quick Ratio
1.941.851.491.361.591.52
Current Ratio
2.832.652.362.222.302.66
Return on Equity (ROE)
25.72%23.67%22.44%21.72%25.52%-
Return on Assets (ROA)
12.52%11.39%10.83%10.10%12.09%-
Return on Capital (ROIC)
15.81%13.91%13.21%12.06%14.23%-
Return on Capital Employed (ROCE)
24.10%22.70%23.40%22.30%25.40%28.20%
Earnings Yield
3.38%3.28%----
FCF Yield
1.04%0.99%----
Dividend Yield
1.82%1.67%----
Payout Ratio
43.04%18.79%54.69%61.14%56.12%49.80%
Total Shareholder Return
1.82%1.67%----
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.